Clinical characteristics, prognostic factors, and a prediction model for overall survival of patients with primary gastrointestinal lymphoma: a single-center retrospective study

Background The gastrointestinal tract is a common site of extranodal non-Hodgkin lymphoma (NHL), with diffuse large B-cell lymphoma (DLBCL) representing the predominant pathological subtype of primary gastrointestinal lymphoma (PGIL). The International Prognostic Index (IPI) and National Comprehensive Cancer Network-IPI (NCCN-IPI) are widely used for prognostic assessment. However, primary gastrointestinal-diffuse large B-cell lymphoma (PGI-DLBCL) differs clinically from intranodal DLBCL, and its prognostic factors and optimal management strategies remain inadequately defined. Comprehensive characterization of the clinical features and development of effective predictive models are essential to improve the understanding and prognostic evaluation of PGI-DLBCL. Methods This retrospective study analyzed the clinical data of 253 patients newly diagnosed with PGIL between December 2012 and June 2021, with a particular focus on the DLBCL subtype. Among the 146 patients with DLBCL, patients were randomly assigned to training and validation cohorts at an 8:2 ratio using a randomization seed of “1234”. Independent prognostic factors were identified using Cox proportional hazards regression analyses. A novel prognostic model was subsequently developed to predict overall survival (OS) at 12, 36, and 60 months. The predictive performance of the model was evaluated using receiver operating characteristic (ROC) curves, area under the curve (AUC) values, calibration curves, and Kaplan–Meier survival analyses. Results Age and the monocyte-to-high-density lipoprotein ratio (MHR) were identified as independent prognostic factors in patients with PGI-DLBCL. Compared with the IPI and NCCN-IPI, the nomogram demonstrated improved predictive performance, particularly for estimating 36- and 60-month OS, as indicated by ROC curve analyses. Conclusion This study systematically characterized the clinical features of PGIL and developed a novel prognostic model for PGI-DLBCL, which may improve the accuracy of patient outcome prediction.

Authors

Institutions

Publication Details

Journal
PeerJ
Published
2026-11-13
DOI
https://doi.org/10.7717/peerj.21905
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical characteristics, prognostic factors, and a prediction model for overall survival of patients with primary gastrointestinal lymphoma: a single-center retrospective study

Sijia Shang, Ning Su, Jiaoting Chen, Guowen Zhao et al.
1 links
PeerJ
Lymphoma Diagnosis and Treatment
article

Clinical characteristics, prognostic factors, and a prediction model for overall survival of patients with primary gastrointestinal lymphoma: a single-center retrospective study

Sijia Shang, Ning Su, Jiaoting Chen, Guowen Zhao, Yuanyuan Yang, Yijia Zheng, Yongju Yi, Min Zhi, Tingzhi Liu, Hongrui Shi, Xing Zhang
article en

Abstract

Background The gastrointestinal tract is a common site of extranodal non-Hodgkin lymphoma (NHL), with diffuse large B-cell lymphoma (DLBCL) representing the predominant pathological subtype of primary gastrointestinal lymphoma (PGIL). The International Prognostic Index (IPI) and National Comprehensive Cancer Network-IPI (NCCN-IPI) are widely used for prognostic assessment. However, primary gastrointestinal-diffuse large B-cell lymphoma (PGI-DLBCL) differs clinically from intranodal DLBCL, and its prognostic factors and optimal management strategies remain inadequately defined. Comprehensive characterization of the clinical features and development of effective predictive models are essential to improve the understanding and prognostic evaluation of PGI-DLBCL. Methods This retrospective study analyzed the clinical data of 253 patients newly diagnosed with PGIL between December 2012 and June 2021, with a particular focus on the DLBCL subtype. Among the 146 patients with DLBCL, patients were randomly assigned to training and validation cohorts at an 8:2 ratio using a randomization seed of “1234”. Independent prognostic factors were identified using Cox proportional hazards regression analyses. A novel prognostic model was subsequently developed to predict overall survival (OS) at 12, 36, and 60 months. The predictive performance of the model was evaluated using receiver operating characteristic (ROC) curves, area under the curve (AUC) values, calibration curves, and Kaplan–Meier survival analyses. Results Age and the monocyte-to-high-density lipoprotein ratio (MHR) were identified as independent prognostic factors in patients with PGI-DLBCL. Compared with the IPI and NCCN-IPI, the nomogram demonstrated improved predictive performance, particularly for estimating 36- and 60-month OS, as indicated by ROC curve analyses. Conclusion This study systematically characterized the clinical features of PGIL and developed a novel prognostic model for PGI-DLBCL, which may improve the accuracy of patient outcome prediction.

PeerJVol. 14
Sun Yat-sen University (CN), Sixth Affiliated Hospital of Sun Yat-sen University (CN)
National Natural Science Foundation of China, Sun Yat-sen University, Wu Jieping Medical Foundation
Good health and well-being
Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon